Key result
Clinical predictive model identifies asymptomatic PE in hospitalized DVT patients with an AUC of ~0.87.
Why the study?
Routine CTPA screening for asymptomatic PE in patients with lower extremity DVT faces resource and contrast-agent limitations, requiring optimized diagnostic strategies to identify high-risk patients needing CTPA.
Does a predictive model integrating clinical characteristics and inflammatory markers accurately identify asymptomatic pulmonary embolism in hospitalized patients with deep vein thrombosis?
Population
401 patients admitted with lower extremity DVT without acute PE symptoms
Comparison
Asymptomatic PE (n=198) vs isolated DVT (n=203)
Design
Retrospective study
Authors
Loading...
May aid risk stratification for asymptomatic PE in DVT; leaves open clinical adoption pending prospective validation.
Observational (n=401)
Does a predictive model integrating clinical characteristics and inflammatory markers accurately identify asymptomatic pulmonary embolism in hospitalized patients with deep vein thrombosis?
Effect estimate: AUC 0.874
A predictive model using routine clinical factors and the neutrophil-to-lymphocyte ratio can accurately identify hospitalized DVT patients at high risk for asymptomatic PE, potentially optimizing the use of CTPA screening.
Mu et al. (2026) conducted an observational in Lower extremity deep vein thrombosis (DVT) (n=401). Clinical and inflammatory risk factors (hypertension, NLR, smoking duration, right DVT, leg swelling/pain) was evaluated on Asymptomatic pulmonary embolism (AUC 0.874). A predictive model integrating hypertension, NLR, smoking duration, right DVT, and leg swelling/pain identified asymptomatic PE in hospitalized DVT patients with an AUC of 0.874.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: